Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$39.64 USD

39.64
546,985

-0.05 (-0.13%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $39.62 -0.02 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for QDEL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for QuidelOrtho Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 167 345 829 490 53
Receivables 303 454 378 498 95
Notes Receivable 0 0 0 0 0
Inventories 578 524 199 114 58
Other Current Assets 262 252 35 41 17
Total Current Assets 1,311 1,575 1,440 1,142 222
Net Property & Equipment 1,444 1,339 349 110 80
Investments & Advances 7 21 38 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 26 16 20 45 25
Intangibles 5,426 5,601 436 459 485
Deposits & Other Assets 180 123 20 14 7
Total Assets 8,563 8,856 2,430 1,871 911
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 13
Accounts Payable 295 283 101 86 27
Current Portion Long-Term Debt 140 208 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 85 139 40 35 17
Income Taxes Payable 11 52 67 128 0
Other Current Liabilities 303 325 105 80 63
Total Current Liabilities 834 1,007 324 337 126
Mortgages 0 0 0 0 0
Deferred Taxes/Income 192 213 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 2,275 2,431 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 84 84 49 101 132
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 3,557 3,921 501 538 351
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,848 2,804 280 388 426
Retained Earnings 2,188 2,198 1,649 945 135
Other Equity -30 -68 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 5,006 4,935 1,929 1,333 560
Total Liabilities & Shareholder's Equity 8,563 8,856 2,430 1,871 911
Total Common Equity 5,006 4,935 1,929 1,333 560
Shares Outstanding 66.80 66.00 41.60 42.00 41.60
Book Value Per Share 74.94 74.77 46.38 31.73 13.46

Fiscal Year End for QuidelOrtho Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 167 193 224 397
Receivables NA 303 331 247 275
Notes Receivable NA 0 0 0 0
Inventories NA 578 552 542 529
Other Current Assets NA 262 295 296 299
Total Current Assets NA 1,311 1,371 1,308 1,499
Net Property & Equipment NA 1,444 1,369 1,376 1,362
Investments & Advances NA 7 12 25 34
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 26 16 16 17
Intangibles NA 5,426 5,419 5,507 5,570
Deposits & Other Assets NA 180 179 141 127
Total Assets NA 8,563 8,539 8,550 8,787
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 295 253 226 242
Current Portion Long-Term Debt NA 140 193 207 208
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 85 107 82 109
Income Taxes Payable NA 11 2 2 16
Other Current Liabilities NA 303 305 273 334
Total Current Liabilities NA 834 860 790 908
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 192 197 200 209
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 2,275 2,275 2,309 2,380
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 65 69 111
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 3,557 3,572 3,548 3,791
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,848 2,839 2,825 2,809
Retained Earnings NA 2,188 2,181 2,194 2,247
Other Equity NA -30 -53 -16 -59
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 5,006 4,967 5,003 4,997
Total Liabilities & Shareholder's Equity NA 8,563 8,539 8,550 8,787
Total Common Equity 0 5,006 4,967 5,003 4,997
Shares Outstanding 66.80 66.80 66.80 66.60 66.60
Book Value Per Share 0.00 74.94 74.35 75.11 75.02